1 Oct 2026, 08:14
Company Administration—
NXNNEXSEN LIMITED
Announcement history available from 1 August 2025
Fromto
25 Sept 2026, 09:40
ReinstatementMS
25 Sept 2026, 09:40
Company UpdateMS
24 Sept 2026, 10:22
Trading Halt / SuspensionMS
24 Sept 2026, 10:21
Company UpdateMS
22 Sept 2026, 09:18
Trading Halt / SuspensionMS
11 Sept 2026, 09:29
Director Interests—
11 Sept 2026, 09:19
Securities Administration—
11 Sept 2026, 09:13
Securities Administration—
31 Aug 2026, 07:55
Company Administration—
31 Aug 2026, 07:54
Financial ResultsMS
29 July 2026, 08:33
Quarterly ReportsMS
23 July 2026, 09:07
Company Update—
30 June 2026, 08:43
Company Administration—
25 June 2026, 08:36
Capital RaisingMS
15 May 2026, 17:11
Substantial Holders—
13 May 2026, 08:55
Company UpdateMS
4 May 2026, 08:17
Company UpdateMS
28 Apr 2026, 09:35
Quarterly ReportsMS
7 Apr 2026, 08:25
Company UpdateMS
31 Mar 2026, 08:31
Periodic ReportsMS
26 Mar 2026, 08:17
Company UpdateMS
23 Mar 2026, 08:26
Company UpdateMS
27 Feb 2026, 09:11
Financial ResultsMS
27 Feb 2026, 09:03
Substantial Holders—
25 Feb 2026, 08:33
Company Administration—
25 Feb 2026, 08:20
Securities Administration—
6 Feb 2026, 08:48
Substantial Holders—
6 Feb 2026, 08:20
Securities Administration—
29 Jan 2026, 19:29
Quarterly ReportsMS
27 Jan 2026, 09:13
Periodic ReportsMS
23 Jan 2026, 14:42
Securities Administration—
6 Jan 2026, 09:18
Company Update—
8 Dec 2025, 08:49
PresentationsMS
5 Dec 2025, 18:16
Director Interests—
3 Dec 2025, 09:14
Company UpdateMS
21 Nov 2025, 16:24
Meetings & Governance—
21 Nov 2025, 09:34
Letters & Addresses—
6 Nov 2025, 09:17
Company Update—
31 Oct 2025, 11:24
Quarterly ReportsMS
24 Oct 2025, 08:42
Meetings & Governance—
21 Oct 2025, 09:01
Company UpdateMS
15 Oct 2025, 16:33
Substantial Holders—
14 Oct 2025, 11:52
Company Administration—
14 Oct 2025, 11:52
Director Interests—
14 Oct 2025, 11:51
Substantial Holders—
14 Oct 2025, 11:51
Letters & Addresses—
10 Oct 2025, 15:22
Company Administration—
10 Oct 2025, 15:21
Company Administration—
10 Oct 2025, 15:18
Company Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 1 Oct 2026, 08:14 | Professor Shekhar Kumta appointed Executive Director | Company Administration | — | 12001, 15002 | |
| 25 Sept 2026, 09:40 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 25 Sept 2026, 09:40 | Proposed FlashDx joint venture builds on CE-marked GBS test | Company Update | MS | 11001 | |
| 24 Sept 2026, 10:22 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 24 Sept 2026, 10:21 | Clear pathway defined to optimise StrepSure | Company Update | MS | 11001 | |
| 22 Sept 2026, 09:18 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 11 Sept 2026, 09:29 | Director Interest Notices re Performance Rights | Director Interests | — | 02009, 06009 | |
| 11 Sept 2026, 09:19 | Notification regarding unquoted securities - NXN | Securities Administration | — | 06021 | |
| 11 Sept 2026, 09:13 | Notification regarding unquoted securities - NXN | Securities Administration | — | 06021 | |
| 31 Aug 2026, 07:55 | Corporate Governance Statement and Appendix 4G | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 07:54 | Annual Report - FY 2026 | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 29 July 2026, 08:33 | Quarterly Report - Q4 FY26 | Quarterly Reports | MS | 19004, 19009 | |
| 23 July 2026, 09:07 | Launch of Hong Kong facility & pipeline expansion | Company Update | — | 11001 | |
| 30 June 2026, 08:43 | Global Healthcare CEO Joins Nexsen Advisory Board | Company Administration | — | 12008 | |
| 25 June 2026, 08:36 | $1.5m non-dilutive ARC funding for manufacturing | Capital Raising | MS | 03022, 11001 | |
| 15 May 2026, 17:11 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 13 May 2026, 08:55 | Nexsen secures first hospital partner in Asia | Company Update | MS | 11001 | |
| 4 May 2026, 08:17 | Nexsen and Universiti Malaya launch joint facility | Company Update | MS | 11001 | |
| 28 Apr 2026, 09:35 | Quarterly Report - Q3 FY26 | Quarterly Reports | MS | 19003, 19008 | |
| 7 Apr 2026, 08:25 | QMS milestone achieved | Company Update | MS | 11001 | |
| 31 Mar 2026, 08:31 | HK$6 million grant awarded to advance Asia-Pacific execution | Periodic Reports | MS | 03014 | |
| 26 Mar 2026, 08:17 | Nexsen accelerates global rollout for StrepSure | Company Update | MS | 11001 | |
| 23 Mar 2026, 08:26 | FDA feedback derisks US approval pathway for StrepSure | Company Update | MS | 11001 | |
| 27 Feb 2026, 09:11 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 27 Feb 2026, 09:03 | Change in substantial holding - Nexsen | Substantial Holders | — | 02002 | |
| 25 Feb 2026, 08:33 | Nexsen highlights GBS strategy at ISSAD 2026 | Company Administration | — | 12008 | |
| 25 Feb 2026, 08:20 | Application for quotation of securities - NXN | Securities Administration | — | 06020 | |
| 6 Feb 2026, 08:48 | Change in substantial holding - Nexsen | Substantial Holders | — | 02002 | |
| 6 Feb 2026, 08:20 | Application for quotation of securities - NXN | Securities Administration | — | 06020 | |
| 29 Jan 2026, 19:29 | Quarterly Report - Q2 FY26 | Quarterly Reports | MS | 19002, 19007 | |
| 27 Jan 2026, 09:13 | $500k govt grant expands GBS project to neonates | Periodic Reports | MS | 03014 | |
| 23 Jan 2026, 14:42 | Notice under ASX Listing Rule 3.10A | Securities Administration | — | 06009 | |
| 6 Jan 2026, 09:18 | Business Update - FDA engagement underway & key appointment | Company Update | — | 11001, 12008 | |
| 8 Dec 2025, 08:49 | Investor Presentation | Presentations | MS | 03026 | |
| 5 Dec 2025, 18:16 | Initial Directors Interest Notice - Kumta | Director Interests | — | 02008 | |
| 3 Dec 2025, 09:14 | Nexsen Appoints Global Clinical Leader to the Board | Company Update | MS | 11001, 12001 | |
| 21 Nov 2025, 16:24 | Results of AGM | Meetings & Governance | — | 08003 | |
| 21 Nov 2025, 09:34 | Chairman's Address to AGM | Letters & Addresses | — | 15002 | |
| 6 Nov 2025, 09:17 | Nexsen accelerates US diagnostics market entry | Company Update | — | 11001 | |
| 31 Oct 2025, 11:24 | Quarterly Report - Q1 FY26 | Quarterly Reports | MS | 19001, 19006 | |
| 24 Oct 2025, 08:42 | Notice of Annual General Meeting | Meetings & Governance | — | 08001, 08004 | |
| 21 Oct 2025, 09:01 | Nexsen launches clinical trial for GBS Rapid Sensor | Company Update | MS | 11001 | |
| 15 Oct 2025, 16:33 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 14 Oct 2025, 11:52 | Nexsen sucessfully lists on ASX | Company Administration | — | 12008 | |
| 14 Oct 2025, 11:52 | Directors Interest Notices | Director Interests | — | 02008 | |
| 14 Oct 2025, 11:51 | Becoming a substantial holder - Muzzin | Substantial Holders | — | 02001 | |
| 14 Oct 2025, 11:51 | Becoming a substantial holder - Nexsen | Letters & Addresses | — | 02001, 16002 | |
| 10 Oct 2025, 15:22 | Pre Quotation Disclosures | Company Administration | — | 06009, 09008, 12008 | |
| 10 Oct 2025, 15:21 | Top 20 Holders | Company Administration | — | 06009, 09008 | |
| 10 Oct 2025, 15:18 | Distribution Schedule | Company Administration | — | 06009, 09008 |
1–50 of 60
1 / 2